The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial
Ahmad Zare Javid,1,2 Majid Aminzadeh,3 Mohammad Hosein Haghighi-zadeh,4 Mona Jamalvandi2,5 1Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Me...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6ac1c7c9cc594f54bcd8520da7f77f3e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6ac1c7c9cc594f54bcd8520da7f77f3e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6ac1c7c9cc594f54bcd8520da7f77f3e2021-12-02T07:19:35ZThe Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial1178-7007https://doaj.org/article/6ac1c7c9cc594f54bcd8520da7f77f3e2020-03-01T00:00:00Zhttps://www.dovepress.com/the-effects-of-synbiotic-supplementation-on-glycemic-status-lipid-prof-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Ahmad Zare Javid,1,2 Majid Aminzadeh,3 Mohammad Hosein Haghighi-zadeh,4 Mona Jamalvandi2,5 1Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 3Pediatric Endoscopy and Metabolism, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 4Department of Biostatistics, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 5Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranCorrespondence: Mona JamalvandiDepartment of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranTel +98 9185877499Email m.jamalvandi71@yahoo.comBackground and Objective: The aim of the present study was to evaluate the effects of synbiotic on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetes mellitus (T1DM) patients.Materials and Methods: In this double-blind clinical trial, 50 T1DM patients were randomly allocated to intervention (n = 25) and control (n = 25) groups and received either synbiotic powder (Lactobacillus sporogenes GBI-30 (probiotic), maltodextrin and fructooligosaccharide (prebiotic)) or placebo 2 g per day for 8 weeks. Fasting blood samples were collected before and after the intervention to measure fasting blood glucose (FBG), insulin concentration, hemoglobin A1c (HbA1c), lipid profile, and biomarkers of oxidative stress such as total antioxidant capacity (TAC) and hs-C-reactive protein (hs-CRP).Results: Supplementation with synbiotic resulted in a significant decrease in the mean serum levels of HbA1c and hs-CRP (p = 0.01 and p = 0.004, respectively), and marginally significant decrease in FBG (p = 0.05) in the intervention group post- intervention. Also, the mean changes of FBG and hs-CRP were significantly lower in the intervention group compared with the control group (p = 0.03 and p = 0.005, respectively). There were no significant changes found in lipid profile in intervention group post-intervention (p≥ 0.05). The mean serum levels of insulin and TAC were significantly increased in the intervention group post-intervention (p = 0.001). There was a significant increase in the mean changes of TAC (p = 0.005) in the intervention group compared with the control group.Conclusion: The 8-week synbiotic supplementation in T1DM patients may be effective in improvement of FBG, HbA1c, insulin, hs-CRP, and TAC.Keywords: type 1 diabetes mellitus, synbiotic, glycemic status, lipid profile, inflammationZare Javid AAminzadeh MHaghighi-zadeh MHJamalvandi MDove Medical Pressarticletype 1 diabetes mellitussynbioticglycemic statuslipid profileinflammationSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 13, Pp 607-617 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
type 1 diabetes mellitus synbiotic glycemic status lipid profile inflammation Specialties of internal medicine RC581-951 |
spellingShingle |
type 1 diabetes mellitus synbiotic glycemic status lipid profile inflammation Specialties of internal medicine RC581-951 Zare Javid A Aminzadeh M Haghighi-zadeh MH Jamalvandi M The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial |
description |
Ahmad Zare Javid,1,2 Majid Aminzadeh,3 Mohammad Hosein Haghighi-zadeh,4 Mona Jamalvandi2,5 1Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 2Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 3Pediatric Endoscopy and Metabolism, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 4Department of Biostatistics, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; 5Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranCorrespondence: Mona JamalvandiDepartment of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IranTel +98 9185877499Email m.jamalvandi71@yahoo.comBackground and Objective: The aim of the present study was to evaluate the effects of synbiotic on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetes mellitus (T1DM) patients.Materials and Methods: In this double-blind clinical trial, 50 T1DM patients were randomly allocated to intervention (n = 25) and control (n = 25) groups and received either synbiotic powder (Lactobacillus sporogenes GBI-30 (probiotic), maltodextrin and fructooligosaccharide (prebiotic)) or placebo 2 g per day for 8 weeks. Fasting blood samples were collected before and after the intervention to measure fasting blood glucose (FBG), insulin concentration, hemoglobin A1c (HbA1c), lipid profile, and biomarkers of oxidative stress such as total antioxidant capacity (TAC) and hs-C-reactive protein (hs-CRP).Results: Supplementation with synbiotic resulted in a significant decrease in the mean serum levels of HbA1c and hs-CRP (p = 0.01 and p = 0.004, respectively), and marginally significant decrease in FBG (p = 0.05) in the intervention group post- intervention. Also, the mean changes of FBG and hs-CRP were significantly lower in the intervention group compared with the control group (p = 0.03 and p = 0.005, respectively). There were no significant changes found in lipid profile in intervention group post-intervention (p≥ 0.05). The mean serum levels of insulin and TAC were significantly increased in the intervention group post-intervention (p = 0.001). There was a significant increase in the mean changes of TAC (p = 0.005) in the intervention group compared with the control group.Conclusion: The 8-week synbiotic supplementation in T1DM patients may be effective in improvement of FBG, HbA1c, insulin, hs-CRP, and TAC.Keywords: type 1 diabetes mellitus, synbiotic, glycemic status, lipid profile, inflammation |
format |
article |
author |
Zare Javid A Aminzadeh M Haghighi-zadeh MH Jamalvandi M |
author_facet |
Zare Javid A Aminzadeh M Haghighi-zadeh MH Jamalvandi M |
author_sort |
Zare Javid A |
title |
The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial |
title_short |
The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial |
title_full |
The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial |
title_fullStr |
The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial |
title_full_unstemmed |
The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial |
title_sort |
effects of synbiotic supplementation on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetic patients. a placebo-controlled, double-blind, randomized clinical trial |
publisher |
Dove Medical Press |
publishDate |
2020 |
url |
https://doaj.org/article/6ac1c7c9cc594f54bcd8520da7f77f3e |
work_keys_str_mv |
AT zarejavida theeffectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial AT aminzadehm theeffectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial AT haghighizadehmh theeffectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial AT jamalvandim theeffectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial AT zarejavida effectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial AT aminzadehm effectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial AT haghighizadehmh effectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial AT jamalvandim effectsofsynbioticsupplementationonglycemicstatuslipidprofileandbiomarkersofoxidativestressintype1diabeticpatientsaplacebocontrolleddoubleblindrandomizedclinicaltrial |
_version_ |
1718399460064624640 |